Hormonal signaling & sexual health

PT-141

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending.

Also known as Bremelanotide

A melanocortin-receptor agonist FDA-approved as bremelanotide for hypoactive sexual desire disorder in premenopausal women.

What it is

PT-141 acts in the central nervous system on melanocortin receptors rather than on blood flow, which makes it mechanistically different from PDE5 inhibitors like sildenafil. Bremelanotide is approved for acquired, generalized HSDD in premenopausal women; other uses are off-label.

What it's studied for

  • Sexual desire and distress measures in the RECONNECT trials
  • Arousal response in men in earlier trials
  • Central melanocortin signaling

How it's used in practice

  • Taken on demand ahead of anticipated activity, not daily
  • Low libido is usually multifactorial — hormones, sleep, medication, relationship and vascular health all belong in the workup first

What you should know before asking about it

  • Prescription medication with a specific approved indication
  • Nausea is the most common effect; transient blood-pressure increase is documented
  • Contraindicated in uncontrolled hypertension or known cardiovascular disease

Frequently asked questions.

What is PT-141?
PT-141 acts in the central nervous system on melanocortin receptors rather than on blood flow, which makes it mechanistically different from PDE5 inhibitors like sildenafil. Bremelanotide is approved for acquired, generalized HSDD in premenopausal women; other uses are off-label.
What is PT-141 studied for?
Published and ongoing research looks at sexual desire and distress measures in the RECONNECT trials; arousal response in men in earlier trials; central melanocortin signaling. These are areas of study, not promised outcomes.
Is PT-141 FDA-approved?
PT-141 is an FDA-approved prescription medication in the United States. It is prescribed only after a clinician review of your labs and history, and it is dispensed by a licensed pharmacy.
How is PT-141 typically used?
Taken on demand ahead of anticipated activity, not daily Low libido is usually multifactorial — hormones, sleep, medication, relationship and vascular health all belong in the workup first Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
What are the risks and unknowns with PT-141?
Prescription medication with a specific approved indication Nausea is the most common effect; transient blood-pressure increase is documented Contraindicated in uncontrolled hypertension or known cardiovascular disease

Sources

  1. 1.Published literature on PT-141 BremelanotidePubMed, U.S. National Library of Medicine
  2. 2.FDA-approved prescribing information for PT-141DailyMed, U.S. National Library of Medicine
  3. 3.Test directory and patient service center locatorQuest Diagnostics

About this page

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on . Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.

This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Compounds identified as research use only are not FDA-approved, are not prescribed as medical care, and are not intended for human or animal consumption. Availability, formulations and regulatory status change over time.